Physician profile
Jonathan Dale Creech
NPI 1922495779
$35,052.38
in general payments reported to CMS, 2019-2025
16 companies · $4,775 in 2025
The $4,775 reported for 2025 was more than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $10K · 2021: $12K · 2022: $912 · 2023: $484 · 2024: $6,295 · 2025: $4,775.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,750 · Travel and Lodging: $3,695 · Food and Beverage: $2,109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,750.00 |
| Travel and Lodging | $3,695.14 |
| Food and Beverage | $2,108.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $21,741.59 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $6,348.49 | 2022-2025 | Rosa, Persona, Tapestry |
| Canary Medical USA LLC | $5,878.61 | 2024 | |
| Stryker Corporation | $668.08 | 2021 | |
| Kala Pharmaceuticals, INC. | $125.00 | 2021 | |
| Flower Orthopedics Coporation | $63.37 | 2025 | |
| Innovation Technologies INC | $38.38 | 2023 | Irrisept |
| Globus Medical, INC. | $27.87 | 2025 | Vyrsa V1 |
| Pacira Pharmaceuticals Incorporated | $27.15 | 2022 | |
| Abbvie INC. | $24.25 | 2022 | |
| Depuy Synthes Sales INC. | $22.76 | 2023 | Na |
| Radius Health, INC. | $20.60 | 2021 | |
| Pacira Therapeutics, INC. | $18.49 | 2021 | |
| Heron Therapeutics, INC. | $18.47 | 2025 | Zynrelef |
| Bioventus LLC | $16.84 | 2025 | Exogen Ultrasound Bone Healing System |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $12.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Creech listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.